Download "The Lost Opportunity in Phase I Oncology Trials," an interview with Medelis co-founder and Medical Advisory Board Chair Dan Von Hoff, M.D., and other issues in our "Peer Perspectives in Oncology" abstract series.
Medelis Europe
An oncology contract research organisation offering unparalleled expertise for your research challenges
As a worldwide oncology CRO, Medelis is helping biotechnology and pharmaceutical companies by delivering the best total solution—and all the support required—to optimize the return on your clinical research investments. And we accomplish that in the quickest, most responsive way possible.
Our approach is driven by a critical mass of clinical research expertise, the ability to identify and focus on the most significant challenges, and your need for prompt results. Our world-class insight and experience in the development and execution of clinical research plans and protocols delivers the decision support you need to chart your next clinical move.
Expertise in European trials
Medelis Europe delivers complete oncology CRO services from preclinical through phase III. European, U.S., and Asian sponsors looking to bring drugs to the U.S. & European markets can take advantage of Medelis’ full service offering, which includes EDC for phase I studies, internet-based patient recruitment, and integrated preclinical studies aligning the preclinical, regulatory and clinical teams.
In addition to our permanent operations in the U.S. and Europe, we use a partnership model that enables us to execute trials as needed in almost any country. This flexibility allows us to access the best sites and patient populations for specific trials while eliminating costly overhead and the need to maintain a network of offices around the globe.
The Medelis Europe division leads projects for European and Asian sponsors
Medelis assigns a U.S.-based global project manager to trials in North and South America
Whether executing a trial in a single country or across multiple continents, Medelis utilizes a streamlined project management model, providing a single point of contact to oversee the people, processes and operations around the world. For sponsors based in North or South America, Medelis appoints a U.S.-based project manager, and our Medelis Europe operation leads projects for sponsors based in Europe and Asia.
» Contact us today to begin a discussion about your trial.
Expertise in Oncology Drug Development
From our advisory board to our project managers and our CRAs, Medelis offers deep experience in every facet of the oncology drug development process at all levels of our organization. Our clinical team members and medical personnel have critical first-hand experience in the complex issues often associated with oncology studies, which means that highly experienced resources will be working on your trial. And whether it’s a standard dose-escalation phase I trial or a complex rescue of a phase III trial, chances are that our team has handled it before.
Medelis' expertise begins with the thought leadership of our world-class Medical Expert Team, a group that delivers a wealth of experience in the design, performance and analysis of oncology clinical trials. These experts are actively involved with our study team, providing immeasurable expertise with study design, site selection, patient populations, and the latest trends and ideas in oncology drug development from around the world.
» Learn more about our oncology expertise
Learn more about Medelis
Read about our full range of oncology CRO services, or we invite you to contact us today.
